Sawas Younus Hammadi and Ameeda Ali
Department of Pathological Analysis, College of Applied Sciences, University of Samarra, Iraq
Received: Feb 22, 2022 / Revised: Mar 10, 2022 / Accepted: Mar 15, 2022
Abstract
Microbes are infectious agents that are invisible to the naked eye and are found all over the world. Some of them cause sickness in humans. Bacteria, fungi, viruses, prions, and protozoa are the different types. Microscopic parasites are also included. The microbiology laboratory’s diagnosis of infection serves two major purposes: clinical and epidemiological. Antibiotics function by reducing the growth of the infecting organism and are used to treat infectious diseases both therapeutically and prophylactically. Some are ‘broad spectrum,’ which means they function against a wide range of pathogenic bacteria, while others are more specific. Despite a large number of antibiotics available, many infecting and disease-causing bacteria remain resistant to them. Many diseases of the developing world fall into this group. Evidence for a protective effect Treatment of normal animals with antibiotics reduces or removes their commensal bacteria and this allows pathogens to infect mucous surfaces more easily. In humans, after treatment with antibiotics for various diseases, secondary infections arise, e.g. oral and vaginal thrush due to Candida albicans, pseudomembranous colitis due to Clostridium difficile, and nasal infections with Staphylococcus aureus.
Keywords Microbes, Laboratory’s diagnosis, Disease-causing bacteria, Secondary infections
How to cite this article
Hammadi, S.Y. and Ali, A. (2022). Role of some microbes and fungal species to treat different infections caused by other microorganisms. Microbial Science Archives, Vol. 2 (1), 5-8. http://dx.doi.org/10.47587/MSA.2022.2102
References
Barnes, E. M., Impey, C. S., & Cooper, D. M. (1980). Competitive exclusion of salmonellas from the newly hatched chick. Veterinary Record.
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson Jr, R. B., … & Pritt, B. S. (2013). A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) a. Clinical infectious diseases, 57(4), e22-e121.
Béahdy, J. (1974). Recent developments of antibiotic research and classification of antibiotics according to chemical structure. Advances in applied microbiology, 18, 309-406.
Berg, R. D., & Owens, W. E. (1979). Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract of mice by bacterial antagonism. Infection and Immunity, 25(3), 820-827.
Brooks, K. (2012). Ready Reference to microbes, 3rd ed., Association for Professionals in Infection Control and Epidemiology, Inc., Washington, DC.
Brown, M. (2014). Microbiology basics. In: APIC Text of Infection Control and Epidemiology, 4th Edition, Clini-cal Editor Grota P. Washington, DC, Association for Professionals in Infection Control and Epidemiolo-gy, Inc., Chapter 24.
Chatterjee, R., Sinha, S., Aggarwal, S., Dimri, A. G., Singh, D., Goyal, P., … & Chacko, K. M. (2012). Studies on susceptibility and resistance patterns of various E. coli isolated from different water samples against clinically significant antibiotics. Int J Bioassays, 1(11), 156-161.
Chauhan, A., Goyal, P., & Varma, A. (2015). In-vitro antibiotic resistance and heavy metal tolerance patterns of gram-positive and gram-negative Bacteria isolated from effluent treated water of Delhi, India. Journal of Current Pharma Research, 5(2), 1449.
Damani, N. (2012). Manual of infection prevention and control, 3rd Ed., Oxford University Press, Oxford, UK.
Diekema, D.J. and Pfaller, M.A. (2015). Prevention of health care-associated infections. In Manual of Clinical Micro-biology, 11th Ed., Jorgensen JH and Pfaller MA, Editors in Chief, ASM Press, Washington, DC. 106-119.
Diekema, D.J. and Saubolle, M.A. (2011). Clinical microbiology and infection prevention. J Clin Microbiol, 49, S57-S60.
Gastmeier, P., Schwab, F., Bärwolff, S., Rüden, H., & Grundmann, H. (2006). Correlation between the genetic diversity of nosocomial pathogens and their survival time in intensive care units. Journal of Hospital Infection, 62(2), 181-186.
Hentges, D. J., & Maier, B. R. (1970). Inhibition of Shigella flexneri by the normal intestinal flora III. Interactions with Bacteroides fragilis strains in vitro. Infection and Immunity, 2(4), 364-370.\
Levison, M. E. (1973). Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginosa and Enterobacteriaceae. Infection and immunity, 8(1), 30-35.
Maier, B. R., & Hentges, D. J. (1972). Experimental Shigella infections in laboratory animals I. Antagonism by human normal flora components in gnotobiotic mice. Infection and immunity, 6(2), 168-173.
Martin, J.F. (1981). Biosynthesis of metabolic products with antimicrobial activities: β-lactam antibiotics, In: SCHAAL, K.P. and PuLVERER, G. (ed.) Actinomycetes, Gustav Fischer Verlag, Stuttgart, pp. 417-434.
Mims, C. A. (1976). The pathogenesis of infectious disease. London: Academic Press.
Morin, A., Saheb, S. A., Bisaillon, J. G., Beaudet, R., & Sylvestre, M. (1980). In vitro inhibition of Neisseria gonorrhoeae growth by strict anaerobes. Infection and Immunity, 28(3), 766-770.
Nishikawa, T., Hatano, H., Ohnishi, N., Sasaki, S., & Nomura, T. (1969). Establishment of Candida albicans in the alimentary tract of the germ‐free mice and antagonism with Escherichia coli after oral inoculation. Japanese Journal of Microbiology, 13(3), 263-276.
Odds, F. C. (1979). Candida and candidosis. Leicester: University of Leicester Press.
Rolfe, R. D., Helebian, S., & Finegold, S. M. (1981). Bacterial interference between Clostridium difficile and normal fecal flora. Journal of infectious Diseases, 143(3), 470-475.
Saigh, J. H., Sanders, C. C., & Sanders Jr, W. E. (1978). Inhibition of Neisseria gonorrhoeae by aerobic and facultatively anaerobic components of the endocervical flora: evidence for a protective effect against infection. Infection and immunity, 19(2), 704-710.\
Savage, D. C. (1972). Survival on mucosal epithelia, epithelial penetration and growth in tissues of pathogenic bacteria. In Symp. Soc. Gen. Microbiol (Vol. 22, pp. 25-57).
Vandamme, E.J., ed. (1984). Biotechnology of Industrial Antibiotics, Marcel Dekker Inc., New York and Basel.
Wannamaker, L. W. (1980). Bacterial interference and competition. Scand. J. infect. Dis. (Suppl.) 24, 82-85.
License Article Metadata
This work is licensed under a Creative Commons Attribution 4.0 International License.
